ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist, Computational Biology at Korro Bio - ApplyBlast

Senior Scientist, Computational Biology

Korro Bio

6 months ago

Remote

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Senior Scientist, Computational Biology at Korro is responsible for driving computational biology analyses across Korro’s research pipeline, including target validation, mechanism-of-action studies, and RNA editing activity characterization in preclinical models. They design and execute NGS-based experiments, collaborate with platform biology, chemistry, and pharmacology teams, develop and maintain reproducible analysis pipelines in R and Python, and provide analytical support to the preclinical-to-clinical translational handoff for GalNAc-conjugated programs.

Responsibilities

Drive computational biology analyses across Korro’s research pipeline
Design and execute NGS-based experiments
Partner with platform biology, chemistry, and pharmacology teams
Develop and maintain reproducible analysis pipelines in R and Python
Provide analytical support to the preclinical-to-clinical translational handoff

Skills

Qualifications

Ph.D. in Computational Biology, Bioinformatics, Genomics, Computational Chemistry, or a related quantitative discipline3+ years of post-PhD experience in a biotech or pharmaceutical industry settingDemonstrated track record of shipped, decision-impacting analyses on industry programsStrong scientific programming in R and/or PythonSolid experience analyzing NGS data

About Korro Bio

korrobio.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

51-200 employees

View Profile

Korro Bio is a biotechnology company developing precision RNA‑editing therapeutics that edit a single letter on RNA to modulate biological pathways. Their mission is to translate this platform into genetic-medicine solutions for complex, prevalent diseases by advancing a focused therapeutic pipeline. The company emphasizes moving its science toward patient‑facing programs and resources (for example, work relevant to AATD) to deliver targeted, durable treatments.